Kymera Therapeutics Inc Free Cash Flow Generation Index

Latest as of December 2023: -0.44x

Kymera Therapeutics Inc free cash flow generation index. Kymera Therapeutics Inc (KYMR) has a Free Cash Flow Generation Index of -0.44x as of December 2023. Free cash flow of $-3.58 Million represents 0% of operating cash flow ($8.04 Million).

FCF Generation Index

-0.44x
Free Cash Flow / Operating CF

Free Cash Flow

$-3.58 Million
USD

Operating Cash Flow

$8.04 Million
USD

Capital Expenditures

$11.62 Million
USD

Free Cash Flow Generation Index of Kymera Therapeutics Inc (2019–2020)

Free cash flow generation index of Kymera Therapeutics Inc from 2019 to 2020. Historical FCF Generation Index trend for Kymera Therapeutics Inc across 2 annual periods. See Kymera Therapeutics Inc (KYMR) flexibility index to measure the company's free cash flow as a share of total liabilities.

Kymera Therapeutics Inc Free Cash Flow Generation Index by Year (2019–2020)

Kymera Therapeutics Inc free cash flow generation index by year from 2019 to 2020. Year-by-year Free Cash Flow Generation Index for Kymera Therapeutics Inc. For the full cash flow conversion analysis, see Kymera Therapeutics Inc (KYMR) cash conversion ratio.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2020 0.90x $79.03 Million $88.13 Million $9.10 Million ▼ -7.6%
2019 0.97x $17.37 Million $17.91 Million $532.00K —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).